Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results
- PMID: 25891096
- DOI: 10.1002/cncy.21542
Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results
Abstract
Background: Testing for the presence of the human papillomavirus (HPV) is widely accepted for triaging Papanicolaou cytology results categorized as atypical squamous cells of undetermined significance (ASC-US). In contrast, HPV testing has limited use in triaging cytological low-grade squamous intraepithelial lesions (LSILs) due to prevalence rates of typically >80%. In the current study, the authors assessed the diagnostic performance of p16/Ki-67 dual-stained cytology in triaging ASC-US and LSIL cases within the prospective, multicentric Primary ASC-US LSIL Marker Study (PALMS).
Methods: A total of 575 ASC-US cases and 529 LSIL cases from a cohort of 27,349 women who were prospectively enrolled into the PALMS study in 5 European countries were tested with p16/Ki-67 dual-stained cytology and Hybrid Capture 2 (HC2) HPV testing. Colposcopy-guided biopsy results of cervical intraepithelial neoplasia of grade 2 or worse (CIN2+) were used as clinical endpoints.
Results: p16/Ki-67 dual-stained cytology demonstrated comparable (ASC-US: 94.4% for dual-stained cytology vs 100% for HC2 testing; P = .317) or lower (LSIL: 85.7% for dual-stained cytology vs 98.4% for HC2 testing; P = .005) sensitivity for CIN2+, but higher levels of specificity compared with HC2 HPV testing in both ASC-US (78.7% vs 60.4%; P<.001) and LSIL (53.3% vs 15.6%; P<.001) cases. Positive predictive values for CIN2+ were substantially higher for dual-stained cytology versus HC2 HPV testing, especially in LSIL, and in ASC-US cases for women aged <30 years.
Conclusions: The clinical usefulness and efficiency of triaging women with ASC-US or LSIL Papanicolaou cytology results by p16/Ki-67 dual-stained cytology testing has been confirmed in this prospective, pan-European study. The high positive predictive value of dual-stained cytology for the presence of high-grade CIN may help to reduce the number of unnecessary colposcopy referrals.
Keywords: CINtec PLUS; Primary ASC-US LSIL Marker Study (PALMS); atypical squamous cells of undetermined significance (ASC-US); cervical cytology; human papillomavirus (HPV); low-grade squamous intraepithelial lesion (LSIL); p16/Ki-67 dual-stained cytology; triage.
© 2015 American Cancer Society.
Similar articles
-
[Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].Zhonghua Fu Chan Ke Za Zhi. 2017 Nov 25;52(11):734-739. doi: 10.3760/cma.j.issn.0529-567X.2017.11.004. Zhonghua Fu Chan Ke Za Zhi. 2017. PMID: 29179267 Chinese.
-
Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study.Cytopathology. 2016 Aug;27(4):269-76. doi: 10.1111/cyt.12317. Epub 2016 Mar 1. Cytopathology. 2016. PMID: 26932360
-
Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA.Anticancer Res. 2015 Nov;35(11):6291-5. Anticancer Res. 2015. PMID: 26504065
-
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD008054. doi: 10.1002/14651858.CD008054.pub2. Cochrane Database Syst Rev. 2013. PMID: 23543559 Free PMC article. Review.
-
A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology.BJOG. 2015 Jan;122(1):64-70. doi: 10.1111/1471-0528.13076. Epub 2014 Sep 11. BJOG. 2015. PMID: 25208923 Review.
Cited by
-
The Role of p16/Ki67 Dual Staining in Cervical Cancer Screening.Curr Issues Mol Biol. 2023 Oct 19;45(10):8476-8491. doi: 10.3390/cimb45100534. Curr Issues Mol Biol. 2023. PMID: 37886977 Free PMC article. Review.
-
Efficiency of CIN2+ Detection by Thyrotropin-Releasing Hormone (TRH) Site-Specific Methylation.Viruses. 2023 Aug 24;15(9):1802. doi: 10.3390/v15091802. Viruses. 2023. PMID: 37766209 Free PMC article.
-
High-risk human papillomavirus genotyping in women with atypical squamous cells of undetermined significance.Sci Rep. 2023 Jul 26;13(1):12134. doi: 10.1038/s41598-023-39206-2. Sci Rep. 2023. PMID: 37495771 Free PMC article.
-
Comparison of HPV 16/18 Genotyping and p16/Ki67 Dual Staining for Detection of High-Grade Cervical Lesion in Patients with Low-Grade Cervical Smears.J Obstet Gynaecol India. 2023 Jun;73(3):248-253. doi: 10.1007/s13224-022-01731-x. Epub 2023 Jan 9. J Obstet Gynaecol India. 2023. PMID: 37324372
-
Evaluation of the clinical performance of p16/Ki-67 dual-staining cytology for cervical lesion detection in premenopausal and postmenopausal Chinese women.J Cancer Res Clin Oncol. 2023 Sep;149(12):10645-10658. doi: 10.1007/s00432-023-04938-1. Epub 2023 Jun 11. J Cancer Res Clin Oncol. 2023. PMID: 37302113
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
